5-HTP: The Supplement SSRIs Replaced — and Why

← Back to articles

5-hydroxytryptophan (5-HTP) is a precursor to serotonin, derived from the seeds of Griffonia simplicifolia. It was intensively studied in the 1970s as a potential antidepressant and sleep aid. The pharmaceutical industry later moved to SSRIs. The reasons for that move — not just commercial — remain relevant for anyone considering 5-HTP today.

The Efficacy Evidence

Early trials of 5-HTP in depression were small, mostly non-blinded, and mixed. A 2002 Cochrane review of 5-HTP and tryptophan for depression concluded the evidence was insufficient to establish efficacy and raised safety concerns. Modern controlled trials of 5-HTP in depression are largely absent. For sleep onset and quality, evidence is also thin — small trials with inconsistent outcomes.

The EMS Incident

In 1989, an epidemic of eosinophilia-myalgia syndrome (EMS) killed 37 people and sickened 1,500+ in the US. The outbreak was traced to L-tryptophan from a specific Japanese manufacturer with a contaminated production process. 5-HTP preparations have since been associated with "peak X" contamination that may cause similar syndromes, though incidence is low. This raised durable questions about product purity in this category.

The Serotonin Syndrome Risk

5-HTP raises brain serotonin through a direct precursor path. Combining it with SSRIs, SNRIs, MAOIs, tramadol, triptans, or other serotonergic agents can precipitate serotonin syndrome — a potentially fatal condition characterised by hyperthermia, autonomic instability, altered mental status, and neuromuscular hyperactivity. Because 5-HTP is available OTC, this risk is often underappreciated.

Why SSRIs Replaced It

SSRIs raise synaptic serotonin through reuptake blockade rather than precursor loading. This is more specific, produces a more predictable pharmacokinetic profile, and is less susceptible to peripheral conversion (which depletes peripheral tryptophan and can cause GI distress and weight changes). SSRIs are not without problems, but they’re a better-characterised tool for depression treatment.

Where It Might Fit

5-HTP is not a first-line recommendation for depression, anxiety, or insomnia in any major guideline. People who insist on trying it should use a pharmaceutical-grade product, start low (50 mg), not combine with any serotonergic medication, and involve a clinician for any clinically meaningful depression.